Please note: In order to keep Hive up to date and provide users with the best features, we are no longer able to fully support Internet Explorer. The site is still available to you, however some sections of the site may appear broken. We would encourage you to move to a more modern browser like Firefox, Edge or Chrome in order to experience the site fully.

Gene and Cellular Immunotherapy for Cancer, Hardback Book

Gene and Cellular Immunotherapy for Cancer Hardback

Edited by Armin Ghobadi, John F. DiPersio

Part of the Cancer Drug Discovery and Development series

Hardback

Description

Clinical and preclinical exploration of gene and cellular immunotherapy have seen rapid growth and interest with the development and approval of five Chimeric Antigen Receptor T-cell (CAR-T) products for lymphoma and myeloma and one Bispecific T-Cell Engager (BiTE) for acute lymphoblastic leukemia (ALL).

These advances have dramatically improved the management of patients with relapsed refractory lymphoma, myeloma and leukemia.

Gene and Cellular Immunotherapy for Cancer offers readers a comprehensive review of current cellular and gene-based immunotherapies.

Divided into eighteen cohesive chapters, this book provides an in-depth and detailed look into cellular-based immunotherapies including CAR-T, TCR-T, TIL, Viral CTLs, NK cells in addition to T/NK cell engagers, focusing on their historical perspectives, biology, development and manufacturing, toxicities and more.   Edited by two leading experts on gene and cellular immunotherapy, the book will feature chapters written by a diverse collection of recognized and up-and-coming experts and researchers in the field, providing oncologists, immunologists, researchers and clinical and basic science trainees with a bench to bedside view of the latest developments in the field.

Information

Save 5%

£129.99

£123.05

 
Free Home Delivery

on all orders

 
Pick up orders

from local bookshops

Information

Also in the Cancer Drug Discovery and Development series  |  View all